BPTH Valuation
Bio Path Holdings Inc
$
0.000
- Overview
- Forecast
- Valuation
- Earnings
BPTH Relative Valuation
BPTH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BPTH is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-3.30
P/B
Median3y
1.59
Median5y
1.44
-348.65
FCF Yield
Median3y
-203.96
Median5y
-131.70
Competitors Valuation Multiple
The average P/S ratio for BPTH's competitors is 0.00, providing a benchmark for relative valuation. Bio Path Holdings Inc Corp (BPTH) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
XYLO
Xylo Technologies Ltd
5.090
USD
-1.64%
TTNP
Titan Pharmaceuticals Inc
4.070
USD
-20.73%
XRTX
XORTX Therapeutics Inc
0.835
USD
-2.91%
OGEN
Oragenics Inc
1.390
USD
-2.80%
LIPO
Lipella Pharmaceuticals Inc
0
USD
-14.62%
EAST
Eastside Distilling Inc
0.887
USD
0.00%
OST
Ostin Technology Group Co Ltd
0.120
USD
-4.01%
ASTI
Ascent Solar Technologies Inc
1.690
USD
-5.59%
RETO
ReTo Eco-Solutions Inc
2.500
USD
-11.97%
NCPL
Netcapital Inc
3.190
USD
-2.45%
FAQ
Is Bio Path Holdings Inc (BPTH) currently overvalued or undervalued?
Bio Path Holdings Inc (BPTH) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of -1.69. The fair price of Bio Path Holdings Inc (BPTH) is between to according to relative valuation methord.
What is Bio Path Holdings Inc (BPTH) fair value?
How does BPTH's valuation metrics compare to the industry average?
What is the current P/B ratio for Bio Path Holdings Inc (BPTH) as of Jul 28 2025?
What is the current FCF Yield for Bio Path Holdings Inc (BPTH) as of Jul 28 2025?
What is the current Forward P/E ratio for Bio Path Holdings Inc (BPTH) as of Jul 28 2025?